Atara Biotherapeutics, Inc. - 10-Q Filing
Atara Biotherapeutics filed its quarterly report for the period ended March 31, 2026, providing financial updates including research and development expenses, general and administrative costs, equity transactions such as warrant activity from public offerings in May 2025 and December 2020, and retained earnings figures.
Tickers: $ATRA